The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
Human NAA30 (also known as MAK3 or NAT12, UniProt accession Q147X3) encodes the catalytic subunit of the N-terminal acetyltransferase C (NatC) complex (aksnes2023natsata pages 1-2, drazic2021humannaa30can pages 1-2). NAA30 belongs to the GCN5-related N-acetyltransferase (GNAT) superfamily and functions in N-terminal protein acetylation, one of the most abundant post-translational modifications in eukaryotes (aksnes2023natsata pages 1-2, aksnes2019cotranslationalposttranslationaland pages 1-2). The gene and its enzymatic function are highly conserved from yeast to humans, with human NAA30 capable of functionally replacing yeast Mak3 in complementation assays (drazic2021humannaa30can pages 1-2, drazic2021humannaa30can pages 2-3).
NAA30 catalyzes the irreversible transfer of an acetyl group from acetyl coenzyme A (acetyl-CoA) to the free α-amino group at the N-terminus of nascent protein chains (grunwald2020divergentarchitectureof pages 1-2, damme2016arolefor pages 1-7, aksnes2019cotranslationalposttranslationaland pages 1-2). This reaction can be described as: protein N-terminus + acetyl-CoA → N-acetyl-protein + CoA. The modification is considered irreversible, as no N-terminal deacetylase has been identified to date (aksnes2019cotranslationalposttranslationaland pages 1-2). NAA30 contains the characteristic GNAT fold required for its catalytic activity (grunwald2020divergentarchitectureof pages 1-2, grunwald2020divergentarchitectureof pages 2-3).
NAA30 does not function alone but operates as part of a heterotrimeric complex consisting of three subunits: NAA30 (the catalytic subunit), NAA35 (the large auxiliary/ribosome-anchoring subunit), and NAA38 (the small auxiliary subunit) (grunwald2020divergentarchitectureof pages 1-2, deng2021molecularmechanismof pages 1-3, aksnes2023natsata pages 2-3). All three subunits are required for normal NatC acetylation activity in vivo (deng2021molecularmechanismof pages 1-3, deng2021molecularmechanismof pages 3-4).
Recent structural studies have revealed the molecular architecture of the NatC complex. The 2020 crystal structure of the Saccharomyces cerevisiae NatC complex showed a strikingly different architecture compared to other N-terminal acetyltransferases (grunwald2020divergentarchitectureof pages 1-2). NAA30 adopts the typical GNAT fold with a conserved CoA-binding motif (grunwald2020divergentarchitectureof pages 2-3). The large auxiliary subunit NAA35 is mostly α-helical and wraps around NAA30 and NAA38, forming an elongated structure with a distinctive "tip" region (grunwald2020divergentarchitectureof pages 1-2, grunwald2020divergentarchitectureof pages 2-3). NAA38 adopts an Sm fold similar to spliceosomal proteins (grunwald2020divergentarchitectureof pages 1-2). The three subunits together create a tunnel in the center of the complex that accommodates the substrate's first four amino acids at the NAA30-NAA35 interface (grunwald2020divergentarchitectureof pages 1-2).
The auxiliary subunits play critical roles beyond structural scaffolding. NAA35 serves as the ribosome anchor, positioning NatC directly underneath the ribosomal exit tunnel for co-translational acetylation (grunwald2020divergentarchitectureof pages 1-2, grunwald2020divergentarchitectureof pages 2-3). NAA38, while initially thought to be dispensable in some contexts, has been shown to increase thermostability and broaden the substrate specificity profile of NatC (aksnes2023natsata pages 1-2, aksnes2023natsata pages 2-3). Recent cryo-EM structures of human NatC complexes with and without NAA38 confirmed that NAA38 affects structural features of both NAA30 and NAA35 (aksnes2023natsata pages 2-3). Inositol hexaphosphate (IP6) has been identified as a stabilizing ligand that binds tightly to NatC and contributes to complex integrity (deng2021molecularmechanismof pages 1-3, deng2021molecularmechanismof pages 3-4).
NatC displays distinctive substrate specificity compared to other N-terminal acetyltransferases. While NatA acetylates small N-terminal residues exposed after methionine removal, and NatB acetylates methionine followed by acidic residues (MD, ME, MN, MQ), NatC acetylates proteins that retain the initiator methionine followed by hydrophobic or amphipathic residues (grunwald2020divergentarchitectureof pages 1-2, aksnes2023natsata pages 2-3, drazic2021humannaa30can pages 2-3).
The canonical human NatC substrate N-terminal sequences include Met-Leu (ML), Met-Ile (MI), Met-Phe (MF), and Met-Trp (MW) (damme2016arolefor pages 1-7, drazic2021humannaa30can pages 2-3). However, proteome-wide studies have expanded this substrate profile to include Met-Val (MV), Met-His (MH), Met-Lys (MK), and Met-Met (MM) N-termini (damme2016arolefor pages 1-7, aksnes2023natsata pages 2-3, damme2016arolefor pages 10-14). Recent yeast studies identified 57 NatC substrates, including some with Met-Tyr (MY), Met-Ala (MA), and Met-Ser (MS) N-termini, indicating even broader specificity than initially appreciated (damme2023expandedinvivo pages 1-2).
Structural analyses revealed that the first four amino acids of substrates contribute to NatC recognition at the NAA30-NAA35 interface (grunwald2020divergentarchitectureof pages 1-2). A sequence-specific, ligand-induced conformational change in NAA30 enables efficient acetylation (grunwald2020divergentarchitectureof pages 1-2). This mechanism differs from NatA and NatB, highlighting the divergent evolution of NAT complexes to recognize distinct substrate pools.
Proteome-wide N-terminomics studies have identified specific NatC substrates. In human cells, NAA30 knockdown experiments combined with positional proteomics identified 46 human NatC substrates whose N-terminal acetylation decreased upon NAA30 depletion (damme2016arolefor pages 1-7, damme2016arolefor pages 10-14). In yeast, 57 NatC substrates were identified using similar approaches (damme2023expandedinvivo pages 1-2). Notably, NatC-type proteins are often only partially acetylated across the cellular protein pool, unlike the near-complete acetylation observed for many NatB substrates (aksnes2023natsata pages 2-3, damme2023expandedinvivo pages 1-2).
Key identified substrates include:
Trafficking proteins: ARL8B (important for lysosomal localization) and ARFRP1/Arl3 (Golgi targeting dependent on acetylation and interaction with the membrane protein SYS1) (damme2016arolefor pages 1-7, varland2023nterminalacetylationshields pages 1-2, varland2023nterminalacetylationshields pages 2-3).
Neddylation machinery: UBE2M/UBC12 and UBE2F, the NEDD8-conjugating E2 enzymes critical for cullin neddylation. Their N-terminal acetylation promotes protein stability and productive interactions with cognate E3 ligases such as DCN1 by allowing burial of the acetylated N-terminus into hydrophobic pockets (varland2023nterminalacetylationshields pages 1-2, aksnes2023natsata pages 3-4).
Mitochondrial proteins: Multiple mitochondrial or organellar proteins were identified among NatC substrates or showed reduced expression upon NAA30 depletion (damme2016arolefor pages 1-7, damme2016arolefor pages 10-14). Computational analysis revealed that mitochondrial targeting sequences (MTS) show strong overrepresentation of NatC-compatible hydrophobic residues at position 2 (nashed2023functionalmappingof pages 1-3).
NAA30 functions primarily as a ribosome-associated, co-translational enzyme in the cytosol (grunwald2020divergentarchitectureof pages 1-2, damme2016arolefor pages 1-7, grunwald2020divergentarchitectureof pages 2-3). Human NatC subunits co-sediment with ribosomes, and structural studies identified a ribosome-binding patch in the elongated tip region of the NatC complex (grunwald2020divergentarchitectureof pages 1-2). This positioning directly underneath the ribosomal exit tunnel enables the complex to acetylate nascent polypeptide chains as they emerge from the ribosome (grunwald2020divergentarchitectureof pages 2-3).
Interestingly, a truncated/splice-associated nuclear isoform of NAA30 has been reported in specific cancer contexts, particularly in glioblastoma-initiating cells and thyroid cancer tissues (grunwald2020divergentarchitectureof pages 1-2, aksnes2023natsata pages 1-2). This nuclear localization appears specific to certain cellular contexts and represents a deviation from the typical ribosome-associated function.
One of the most significant recent discoveries is that NatC-mediated N-terminal acetylation serves as a protective mechanism against protein degradation (varland2023nterminalacetylationshields pages 1-2, varland2023nterminalacetylationshields pages 2-3). Genome-wide CRISPR knockout screens in human HAP1 cells revealed strong genetic interactions between NatC subunits and components of the Arg/N-degron pathway, particularly the E3 ubiquitin ligases UBR4-KCMF1, UBR1, and UBR2 (varland2023nterminalacetylationshields pages 1-2, varland2023nterminalacetylationshields pages 2-3, varland2023nterminalacetylationshields pages 3-4).
The molecular mechanism is now understood: unacetylated proteins bearing an N-terminal methionine followed by a hydrophobic residue are recognized by these ubiquitin ligases as N-degrons and targeted for proteasomal degradation (varland2023nterminalacetylationshields pages 1-2, varland2023nterminalacetylationshields pages 3-4). N-terminal acetylation by NatC shields these hydrophobic N-termini from recognition by the degradation machinery (varland2023nterminalacetylationshields pages 1-2, varland2023nterminalacetylationshields pages 2-3). Remarkably, NatC knockout-induced protein degradation and cellular phenotypes can be reversed by UBR knockdown, demonstrating the central importance of this interplay (varland2023nterminalacetylationshields pages 1-2, varland2023nterminalacetylationshields pages 2-3, varland2023nterminalacetylationshields pages 3-4).
NatC plays a critical role in the cullin neddylation pathway through acetylation of the NEDD8-conjugating enzymes UBE2M and UBE2F (varland2023nterminalacetylationshields pages 1-2, aksnes2023natsata pages 3-4). Acetylation of these E2 enzymes serves dual functions: it protects them from degradation and increases their affinity for E3 ligases, promoting efficient cullin neddylation (varland2023nterminalacetylationshields pages 1-2). Structural analysis showed that the acetylated N-terminus of UBE2M is buried within a hydrophobic pocket of DCN1, enhancing cullin neddylation activity (varland2023nterminalacetylationshields pages 1-2). This acetylation-dependent interaction can be antagonized by small molecule inhibitors, suggesting potential therapeutic applications.
NAA30/NatC is essential for mitochondrial integrity and function (damme2016arolefor pages 1-7, aksnes2023natsata pages 3-4, damme2016arolefor pages 10-14). Knockdown of NAA30 in human cells causes mitochondrial fragmentation and loss of mitochondrial membrane potential (damme2016arolefor pages 1-7, aksnes2023natsata pages 3-4, damme2016arolefor pages 10-14). These effects occur independently of p53 pathways and are accompanied by reduced expression levels of mitochondrial matrix proteins (damme2016arolefor pages 1-7, damme2016arolefor pages 10-14).
The molecular basis for this mitochondrial requirement is becoming clearer. Computational analysis revealed that mitochondrial targeting sequences (MTS) show specific overrepresentation of hydrophobic residues at position 2, matching the NatC substrate profile (nashed2023functionalmappingof pages 1-3). Systematic mutagenesis of position 2 in a yeast mitochondrial protein confirmed its critical role in mitochondrial protein import (nashed2023functionalmappingof pages 1-3). These findings provide a molecular explanation for mitochondrial defects observed in NatC-depleted cells across species (nashed2023functionalmappingof pages 1-3).
Consistent with these cellular observations, yeast NatC mutants show poor growth on non-fermentable carbon sources like glycerol and ethanol, indicating mitochondrial dysfunction (drazic2021humannaa30can pages 1-2, drazic2021humannaa30can pages 2-3, damme2023expandedinvivo pages 1-2). Similarly, plant NatC (AtNAA30) is required for efficient photosynthesis in chloroplasts (drazic2021humannaa30can pages 2-3).
NatC is intimately involved in Golgi vesicle transport and the secretory pathway (varland2023nterminalacetylationshields pages 2-3, varland2023nterminalacetylationshields pages 3-4). CRISPR genetic interaction screens identified negative genetic interactions between NAA35 and genes involved in Golgi vesicle transport, endosomal transport, and virion assembly (varland2023nterminalacetylationshields pages 2-3, varland2023nterminalacetylationshields pages 3-4). Key interacting genes include ARL1, ARFRP1, SYS1, RAB1A/B, RAB2A, RAB14, and components of the conserved oligomeric Golgi (COG) complex (COG5, COG7) (varland2023nterminalacetylationshields pages 2-3, varland2023nterminalacetylationshields pages 3-4).
The molecular mechanism involves NatC-mediated acetylation of small GTPases. For example, ARFRP1/Arl3 requires N-terminal acetylation for correct targeting to the trans-Golgi network, mediated by interaction of the acetylated N-terminus with the membrane protein SYS1 (varland2023nterminalacetylationshields pages 1-2, drazic2021humannaa30can pages 2-3, varland2023nterminalacetylationshields pages 2-3). Similarly, ARL8B depends on NAA30-mediated acetylation for lysosomal localization (damme2016arolefor pages 1-7, varland2023nterminalacetylationshields pages 1-2). Depletion of human NAA30 induces fragmentation of the Golgi stack, suggesting additional NatC targets at the Golgi beyond ARFRP1 (grunwald2020divergentarchitectureof pages 1-2, grunwald2020divergentarchitectureof pages 2-3).
NAA30 contributes to cell growth, survival, and organismal development (grunwald2020divergentarchitectureof pages 1-2, aksnes2023natsata pages 2-3, aksnes2023natsata pages 3-4). Knockdown of NAA30 in human cells leads to stabilization of p53 and induction of downstream proapoptotic genes, resulting in apoptosis (aksnes2023natsata pages 2-3, aksnes2023natsata pages 3-4). In glioblastoma-initiating cells, NAA30 knockdown reduces cell viability, sphere-forming ability, and hypoxia tolerance (grunwald2020divergentarchitectureof pages 1-2, aksnes2023natsata pages 2-3). Mice transplanted with NAA30-knockdown glioblastoma cells show prolonged survival compared to controls, suggesting NAA30 as a potential therapeutic target in cancer (grunwald2020divergentarchitectureof pages 1-2).
Developmental roles are evident across species. Zebrafish knockouts of NAA30 or NAA35 led to decreased cell proliferation, increased apoptosis, and poor blood vessel formation, resulting in embryonic lethality (grunwald2020divergentarchitectureof pages 2-3). In Drosophila melanogaster, loss of NatC is associated with male sterility, reduced longevity, and age-dependent loss of motility due to developmental muscle defects (varland2023nterminalacetylationshields pages 1-2, varland2023nterminalacetylationshields pages 2-3). Remarkably, muscle-specific overexpression of UbcE2M (Drosophila UBE2M homolog) suppresses the longevity and motility defects of NatC deletion, demonstrating the functional importance of protecting this key substrate from degradation (varland2023nterminalacetylationshields pages 1-2, varland2023nterminalacetylationshields pages 2-3).
In Caenorhabditis elegans, NatC appears to play a regulatory role in response to nutrient availability and stress, coordinating the balance between growth/development and stress responses/energy-saving quiescence (aksnes2023natsata pages 3-4).
NatC function is linked to stress resistance and aging across multiple organisms (drazic2021humannaa30can pages 1-2, varland2023nterminalacetylationshields pages 1-2, drazic2021humannaa30can pages 2-3). Yeast NatC mutants display osmotic sensitivity and reduced growth under high salt stress (drazic2021humannaa30can pages 2-3, damme2023expandedinvivo pages 1-2). In plants, drought stress downregulates NatA while NatC appears involved in adaptive responses (aksnes2019cotranslationalposttranslationaland pages 1-2).
Most compellingly, recent studies demonstrate that NatC-mediated N-terminal acetylation acts as a protective mechanism relevant for increased longevity and motility in aging organisms (varland2023nterminalacetylationshields pages 1-2, varland2023nterminalacetylationshields pages 2-3). The protection of proteins from degradation, particularly in muscle tissue, contributes to healthy aging phenotypes.
NAA30 is increasingly implicated in human disease, particularly cancer (grunwald2020divergentarchitectureof pages 1-2, aksnes2023natsata pages 1-2, aksnes2023natsata pages 2-3). Strong upregulation of NAA30 has been observed in glioblastoma samples at the protein level (grunwald2020divergentarchitectureof pages 1-2, aksnes2023natsata pages 2-3). High NAA30 expression is associated with poor survival in certain cancer types (aksnes2023natsata pages 2-3). Additionally, a likely pathogenic NAA30 variant has been suggested to cause global developmental delay and tracheal cleft, underscoring the importance of NAA30 function in human development (varland2023nterminalacetylationshields pages 1-2, varland2023nterminalacetylationshields pages 2-3).
Loss-of-function variants in genes encoding acetyltransferases can lead to congenital disorders characterized by intellectual disability and heart/muscle defects (keller2024acetyltransferaseincardiovascular pages 1-3). While most pathogenic NAT variants identified to date affect NatA subunits (NAA10, NAA15) or NatB subunits (NAA20), the identification of disease-associated NAA30 variants suggests that systematic screening of NAT genes in developmental disorders is warranted.
| Category | Summary | Key specifics/examples | Evidence |
|---|---|---|---|
| Gene/protein identity | Human NAA30 (also called MAK3, NAT12) is the catalytic subunit of the NatC N-terminal acetyltransferase complex. It belongs to the GNAT-family acetyltransferases and functions in co-translational protein N-terminal acetylation. | NatC is conserved from yeast to human; human NAA30 can functionally replace yeast Mak3/Naa30 in complementation assays. | (drazic2021humannaa30can pages 1-2, damme2016arolefor pages 1-7, aksnes2019cotranslationalposttranslationaland pages 1-2) |
| Enzymatic reaction | NAA30 catalyzes transfer of an acetyl group from acetyl-CoA to the free α-amino group at the protein N-terminus of nascent substrates. | Reaction: protein N-terminus + acetyl-CoA → N-acetyl-protein + CoA; modification is generally considered irreversible. | (grunwald2020divergentarchitectureof pages 1-2, damme2016arolefor pages 1-7, aksnes2019cotranslationalposttranslationaland pages 1-2) |
| NatC complex composition | NatC is a heterotrimeric complex composed of NAA30 (catalytic), NAA35 (large auxiliary/ribosome-anchoring subunit), and NAA38 (small auxiliary subunit). | Structural work shows NAA30 adopts the GNAT fold; NAA35 and NAA38 stabilize the complex; NAA38 broadens substrate specificity and increases thermostability. | (grunwald2020divergentarchitectureof pages 1-2, deng2021molecularmechanismof pages 1-3, aksnes2023natsata pages 2-3, grunwald2020divergentarchitectureof pages 2-3) |
| Substrate specificity: general rule | NatC acetylates proteins that retain the initiator methionine and usually have a hydrophobic or amphipathic residue at position 2. Residues at positions 3-4 also contribute to recognition. | Human NatC/NAA30 is described as modifying Met-starting proteins not targeted by NatB. Structural studies indicate the first four substrate residues contribute to recognition. | (grunwald2020divergentarchitectureof pages 1-2, deng2021molecularmechanismof pages 1-3, aksnes2023natsata pages 2-3, varland2023nterminalacetylationshields pages 1-2) |
| Substrate specificity: canonical human sequences | Canonical human NatC-type N-termini include ML, MI, MF, MW and expanded in vivo classes include MV, MH, MK, MM. | The 2016 human N-terminomics study identified 46 direct/likely human NatC substrates and expanded specificity beyond the classic ML/MI/MF/MW set. | (damme2016arolefor pages 1-7, damme2016arolefor pages 10-14) |
| Substrate specificity: broader recent view | Recent reviews also summarize human NatC substrates as including ML, MI, MF, MV, MY, MW, MH, MK; yeast work shows overlap and some redundancy with NatE/Naa50 for certain methionine-starting N-termini. | This indicates NatC specificity is broader than originally appreciated, though not every compatible N-terminus is fully acetylated in vivo. | (aksnes2023natsata pages 2-3, damme2023expandedinvivo pages 1-2) |
| Acetylation coverage and scale | NatC is one of the major human NATs and, together with NatE/F, covers a substantial subset of methionine-retaining proteins; human cells showed 46 NAA30-dependent substrates and yeast 57 NatC substrates in proteome-scale analyses. | NatC-type proteins are often only partially acetylated across the cellular protein pool, unlike many NatB substrates. | (aksnes2023natsata pages 2-3, damme2023expandedinvivo pages 1-2, damme2016arolefor pages 10-14) |
| Known substrate examples: trafficking proteins | NAA30/NatC acetylates proteins involved in membrane trafficking and organelle targeting. | ARL8B/hArl8b is a validated human NatC substrate important for lysosomal localization; ARFRP1/Arl3 localization to Golgi depends on NatC-mediated N-terminal acetylation and interaction with SYS1. | (damme2016arolefor pages 1-7, varland2023nterminalacetylationshields pages 1-2, drazic2021humannaa30can pages 2-3, varland2023nterminalacetylationshields pages 2-3) |
| Known substrate examples: neddylation pathway | NatC-mediated acetylation is important for the cullin neddylation machinery. | UBE2M/UBC12 and UBE2F are particularly important NatC-relevant targets; their N-terminal acetylation promotes stability and productive interaction with cognate E3 ligases such as DCN1. | (varland2023nterminalacetylationshields pages 1-2, aksnes2023natsata pages 3-4) |
| Known substrate examples: mitochondrial/organellar proteins | Proteomics and phenotype analyses indicate that multiple mitochondrial or organellar proteins are directly or indirectly affected by NAA30 loss. | Human NAA30 depletion reduced levels of several mitochondrial proteins; some were identified among NatC substrates in organellar fractions. | (damme2016arolefor pages 1-7, damme2016arolefor pages 10-14) |
| Subcellular localization of function | NAA30 primarily functions as a ribosome-associated, co-translational enzyme in the cytosol as part of NatC. | Human NatC subunits co-sediment with ribosomes; structural work identified a ribosome-binding patch in NatC. A truncated/splice-associated nuclear NAA30 isoform has also been reported in some cancer contexts. | (grunwald2020divergentarchitectureof pages 1-2, damme2016arolefor pages 1-7, grunwald2020divergentarchitectureof pages 2-3) |
| Pathway/process: protein quality control | A major current model is that NatC-mediated N-terminal acetylation shields hydrophobic Met-starting proteins from degradation by the Arg/N-degron pathway. | Unacetylated NatC-type N-termini are recognized by UBR4-KCMF1, UBR1, and UBR2; NatC knockout phenotypes can be reversed by disrupting these ubiquitin ligases. | (varland2023nterminalacetylationshields pages 1-2, aksnes2023natsata pages 3-4, varland2023nterminalacetylationshields pages 3-4) |
| Pathway/process: Golgi and vesicle trafficking | NatC is linked to Golgi vesicle transport, endosomal transport, and secretory pathway organization. | CRISPR genetic interaction screens in human cells found negative interactions with ARL1, ARFRP1, SYS1, RAB1A/B, RAB2A, RAB14, COG5, COG7 and enrichment for Golgi vesicle transport pathways. | (varland2023nterminalacetylationshields pages 2-3, varland2023nterminalacetylationshields pages 3-4) |
| Pathway/process: mitochondrial integrity | NatC/NAA30 supports mitochondrial membrane potential, morphology, and likely import/biogenesis of selected proteins. | NAA30 knockdown caused mitochondrial fragmentation and loss of membrane potential; yeast and comparative analyses suggest mitochondrial targeting sequences are enriched for NatC-compatible residue patterns. | (damme2016arolefor pages 1-7, nashed2023functionalmappingof pages 1-3, aksnes2023natsata pages 3-4, damme2023expandedinvivo pages 1-2) |
| Pathway/process: cell survival and proliferation | NAA30 contributes to cell growth and survival. | Knockdown of NAA30 stabilizes p53 and induces apoptosis; in glioblastoma-initiating cells, NAA30 knockdown reduces viability, sphere formation, and hypoxia tolerance. | (grunwald2020divergentarchitectureof pages 1-2, aksnes2023natsata pages 2-3, aksnes2023natsata pages 3-4) |
| Disease/cancer relevance | NAA30 is increasingly implicated in cancer biology, especially glioblastoma, and NAT dysregulation more broadly is disease-relevant. | NAA30 protein upregulation has been reported in glioblastoma; orthotopic xenograft studies found longer survival in mice receiving NAA30-knockdown glioblastoma cells. | (grunwald2020divergentarchitectureof pages 1-2, aksnes2023natsata pages 2-3) |
| Key phenotypes of NAA30 loss in human cells | Loss of NAA30 causes distinct cell biological defects rather than a generic collapse of all organelles. | Reported phenotypes include mitochondrial fragmentation, loss of mitochondrial membrane potential, reduced expression of mitochondrial matrix proteins, Golgi fragmentation, reduced cell growth, and apoptosis. | (damme2016arolefor pages 1-7, grunwald2020divergentarchitectureof pages 2-3, aksnes2023natsata pages 3-4) |
| Key phenotypes in model organisms | NatC deficiency causes conserved organismal and stress phenotypes across species. | Yeast NatC mutants show poor growth on non-fermentable carbon sources and salt/stress sensitivity; Drosophila NatC loss causes reduced longevity, age-dependent motility defects, and male sterility; zebrafish knockout data indicate developmental defects. | (drazic2021humannaa30can pages 1-2, varland2023nterminalacetylationshields pages 1-2, grunwald2020divergentarchitectureof pages 2-3, damme2023expandedinvivo pages 1-2) |
| Practical interpretation | The best-supported primary function of human NAA30 is co-translational N-terminal acetylation of a methionine-retaining, largely hydrophobic-starting subset of proteins, thereby regulating their stability, targeting, and organelle-related functions. | Particularly strong mechanistic support exists for roles in N-degron shielding, Golgi/vesicle trafficking, cullin neddylation via UBE2M/UBE2F, and mitochondrial integrity. | (damme2016arolefor pages 1-7, varland2023nterminalacetylationshields pages 1-2, varland2023nterminalacetylationshields pages 2-3, aksnes2023natsata pages 3-4) |
Table: This table summarizes the main experimentally supported properties of human NAA30 and the NatC complex, including composition, substrate rules, representative substrates, localization, pathways, and loss-of-function phenotypes. It is useful as a compact evidence map for functional annotation.
NAA30 (N-alpha-acetyltransferase 30) functions as the catalytic subunit of the heterotrimeric NatC complex, which catalyzes the co-translational N-terminal acetylation of proteins bearing methionine followed by hydrophobic residues at their N-terminus. This modification, performed at the ribosome, serves multiple critical cellular functions:
Protein quality control: N-terminal acetylation shields hydrophobic N-termini from recognition by the Arg/N-degron pathway, preventing premature protein degradation.
Organelle function: NatC is essential for mitochondrial integrity and function, likely through acetylation of mitochondrial-destined proteins, and plays important roles in Golgi/vesicle trafficking.
Signaling pathways: NatC acetylates key components of the cullin neddylation pathway (UBE2M, UBE2F), affecting ubiquitination networks.
Development and aging: NatC activity is required for normal development across species and contributes to longevity and age-dependent motility.
The evolutionary conservation of NatC from yeast to humans, combined with the diverse phenotypes associated with its loss, underscores the fundamental importance of N-terminal acetylation in eukaryotic cell biology. Recent structural and functional studies have provided unprecedented molecular insights into how NatC recognizes and acetylates specific substrates, and how this modification integrates into cellular protein homeostasis networks. As a potential therapeutic target in cancer and a gene implicated in developmental disorders, NAA30 represents an important focus for future research in both basic biology and translational medicine.
References
(aksnes2023natsata pages 1-2): Henriette Aksnes, Nina McTiernan, and Thomas Arnesen. Nats at a glance. Journal of cell science, Jul 2023. URL: https://doi.org/10.1242/jcs.260766, doi:10.1242/jcs.260766. This article has 20 citations and is from a domain leading peer-reviewed journal.
(drazic2021humannaa30can pages 1-2): Adrian Drazic and Sylvia Varland. Human naa30 can rescue yeast mak3∆ mutant growth phenotypes. Bioscience Reports, Mar 2021. URL: https://doi.org/10.1042/bsr20202828, doi:10.1042/bsr20202828. This article has 10 citations and is from a peer-reviewed journal.
(aksnes2019cotranslationalposttranslationaland pages 1-2): Henriette Aksnes, Rasmus Ree, and Thomas Arnesen. Co-translational, post-translational, and non-catalytic roles of n-terminal acetyltransferases. Molecular cell, 73 6:1097-1114, Mar 2019. URL: https://doi.org/10.1016/j.molcel.2019.02.007, doi:10.1016/j.molcel.2019.02.007. This article has 277 citations and is from a highest quality peer-reviewed journal.
(drazic2021humannaa30can pages 2-3): Adrian Drazic and Sylvia Varland. Human naa30 can rescue yeast mak3∆ mutant growth phenotypes. Bioscience Reports, Mar 2021. URL: https://doi.org/10.1042/bsr20202828, doi:10.1042/bsr20202828. This article has 10 citations and is from a peer-reviewed journal.
(grunwald2020divergentarchitectureof pages 1-2): Stephan Grunwald, Linus V. M. Hopf, Tobias Bock-Bierbaum, Ciara C. M. Lally, Christian M. T. Spahn, and Oliver Daumke. Divergent architecture of the heterotrimeric natc complex explains n-terminal acetylation of cognate substrates. Nature Communications, Nov 2020. URL: https://doi.org/10.1038/s41467-020-19321-8, doi:10.1038/s41467-020-19321-8. This article has 39 citations and is from a highest quality peer-reviewed journal.
(damme2016arolefor pages 1-7): Petra Van Damme, Thomas V. Kalvik, Kristian K. Starheim, Veronique Jonckheere, Line M. Myklebust, Gerben Menschaert, Jan Erik Varhaug, Kris Gevaert, and Thomas Arnesen. A role for human n-alpha acetyltransferase 30 (naa30) in maintaining mitochondrial integrity. Molecular & Cellular Proteomics, 15:3361-3372, Nov 2016. URL: https://doi.org/10.1074/mcp.m116.061010, doi:10.1074/mcp.m116.061010. This article has 68 citations and is from a domain leading peer-reviewed journal.
(grunwald2020divergentarchitectureof pages 2-3): Stephan Grunwald, Linus V. M. Hopf, Tobias Bock-Bierbaum, Ciara C. M. Lally, Christian M. T. Spahn, and Oliver Daumke. Divergent architecture of the heterotrimeric natc complex explains n-terminal acetylation of cognate substrates. Nature Communications, Nov 2020. URL: https://doi.org/10.1038/s41467-020-19321-8, doi:10.1038/s41467-020-19321-8. This article has 39 citations and is from a highest quality peer-reviewed journal.
(deng2021molecularmechanismof pages 1-3): Sunbin Deng, Leah Gottlieb, Buyan Pan, Julianna Supplee, Xuepeng Wei, E James Petersson, and Ronen Marmorstein. Molecular mechanism of n-terminal acetylation by the ternary natc complex. Oct 2021. URL: https://doi.org/10.1016/j.str.2021.05.003, doi:10.1016/j.str.2021.05.003. This article has 13 citations and is from a domain leading peer-reviewed journal.
(aksnes2023natsata pages 2-3): Henriette Aksnes, Nina McTiernan, and Thomas Arnesen. Nats at a glance. Journal of cell science, Jul 2023. URL: https://doi.org/10.1242/jcs.260766, doi:10.1242/jcs.260766. This article has 20 citations and is from a domain leading peer-reviewed journal.
(deng2021molecularmechanismof pages 3-4): Sunbin Deng, Leah Gottlieb, Buyan Pan, Julianna Supplee, Xuepeng Wei, E James Petersson, and Ronen Marmorstein. Molecular mechanism of n-terminal acetylation by the ternary natc complex. Oct 2021. URL: https://doi.org/10.1016/j.str.2021.05.003, doi:10.1016/j.str.2021.05.003. This article has 13 citations and is from a domain leading peer-reviewed journal.
(damme2016arolefor pages 10-14): Petra Van Damme, Thomas V. Kalvik, Kristian K. Starheim, Veronique Jonckheere, Line M. Myklebust, Gerben Menschaert, Jan Erik Varhaug, Kris Gevaert, and Thomas Arnesen. A role for human n-alpha acetyltransferase 30 (naa30) in maintaining mitochondrial integrity. Molecular & Cellular Proteomics, 15:3361-3372, Nov 2016. URL: https://doi.org/10.1074/mcp.m116.061010, doi:10.1074/mcp.m116.061010. This article has 68 citations and is from a domain leading peer-reviewed journal.
(damme2023expandedinvivo pages 1-2): Petra Van Damme, Camilla Osberg, Veronique Jonckheere, Nina Glomnes, Kris Gevaert, Thomas Arnesen, and Henriette Aksnes. Expanded in vivo substrate profile of the yeast n-terminal acetyltransferase natc. Journal of Biological Chemistry, 299:102824, Feb 2023. URL: https://doi.org/10.1016/j.jbc.2022.102824, doi:10.1016/j.jbc.2022.102824. This article has 20 citations and is from a domain leading peer-reviewed journal.
(varland2023nterminalacetylationshields pages 1-2): Sylvia Varland, Rui Duarte Silva, Ine Kjosås, Alexandra Faustino, Annelies Bogaert, Maximilian Billmann, Hadi Boukhatmi, Barbara Kellen, Michael Costanzo, Adrian Drazic, Camilla Osberg, Katherine Chan, Xiang Zhang, Amy Hin Yan Tong, Simonetta Andreazza, Juliette J. Lee, Lyudmila Nedyalkova, Matej Ušaj, Alexander J. Whitworth, Brenda J. Andrews, Jason Moffat, Chad L. Myers, Kris Gevaert, Charles Boone, Rui Gonçalo Martinho, and Thomas Arnesen. N-terminal acetylation shields proteins from degradation and promotes age-dependent motility and longevity. Nature Communications, Oct 2023. URL: https://doi.org/10.1038/s41467-023-42342-y, doi:10.1038/s41467-023-42342-y. This article has 96 citations and is from a highest quality peer-reviewed journal.
(varland2023nterminalacetylationshields pages 2-3): Sylvia Varland, Rui Duarte Silva, Ine Kjosås, Alexandra Faustino, Annelies Bogaert, Maximilian Billmann, Hadi Boukhatmi, Barbara Kellen, Michael Costanzo, Adrian Drazic, Camilla Osberg, Katherine Chan, Xiang Zhang, Amy Hin Yan Tong, Simonetta Andreazza, Juliette J. Lee, Lyudmila Nedyalkova, Matej Ušaj, Alexander J. Whitworth, Brenda J. Andrews, Jason Moffat, Chad L. Myers, Kris Gevaert, Charles Boone, Rui Gonçalo Martinho, and Thomas Arnesen. N-terminal acetylation shields proteins from degradation and promotes age-dependent motility and longevity. Nature Communications, Oct 2023. URL: https://doi.org/10.1038/s41467-023-42342-y, doi:10.1038/s41467-023-42342-y. This article has 96 citations and is from a highest quality peer-reviewed journal.
(aksnes2023natsata pages 3-4): Henriette Aksnes, Nina McTiernan, and Thomas Arnesen. Nats at a glance. Journal of cell science, Jul 2023. URL: https://doi.org/10.1242/jcs.260766, doi:10.1242/jcs.260766. This article has 20 citations and is from a domain leading peer-reviewed journal.
(nashed2023functionalmappingof pages 1-3): Salomé Nashed, Houssam El Barbry, Médine Benchouaia, Angélie Dijoux-Maréchal, T. Delaveau, Nadia Ruiz-Gutierrez, Lucie Gaulier, D. Tribouillard-Tanvier, Guillaume Chevreux, S. Le Crom, Benoît Palancade, F. Devaux, É. Laine, and Mathilde Garcia. Functional mapping of n-terminal residues in the yeast proteome uncovers novel determinants for mitochondrial protein import. PLOS Genetics, Aug 2023. URL: https://doi.org/10.1101/2022.08.19.504527, doi:10.1101/2022.08.19.504527. This article has 5 citations and is from a domain leading peer-reviewed journal.
(varland2023nterminalacetylationshields pages 3-4): Sylvia Varland, Rui Duarte Silva, Ine Kjosås, Alexandra Faustino, Annelies Bogaert, Maximilian Billmann, Hadi Boukhatmi, Barbara Kellen, Michael Costanzo, Adrian Drazic, Camilla Osberg, Katherine Chan, Xiang Zhang, Amy Hin Yan Tong, Simonetta Andreazza, Juliette J. Lee, Lyudmila Nedyalkova, Matej Ušaj, Alexander J. Whitworth, Brenda J. Andrews, Jason Moffat, Chad L. Myers, Kris Gevaert, Charles Boone, Rui Gonçalo Martinho, and Thomas Arnesen. N-terminal acetylation shields proteins from degradation and promotes age-dependent motility and longevity. Nature Communications, Oct 2023. URL: https://doi.org/10.1038/s41467-023-42342-y, doi:10.1038/s41467-023-42342-y. This article has 96 citations and is from a highest quality peer-reviewed journal.
(keller2024acetyltransferaseincardiovascular pages 1-3): Mariko Aoyagi Keller and Michinari Nakamura. Acetyltransferase in cardiovascular disease and aging. The journal of cardiovascular aging, Dec 2024. URL: https://doi.org/10.20517/jca.2024.21, doi:10.20517/jca.2024.21. This article has 12 citations.